Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-23
1996-04-16
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 70, A61K 3144, C07D47104
Patent
active
055082840
ABSTRACT:
The present invention provides novel tetrahydro-beta-carboline compounds having useful central nervous system activity. Further, there is provided 3-ethanamine and 3-ethanamine related compounds which are useful intermediates and have beneficial central nervous system activity. The invention provides formulations and methods for using the novel tetrahydro-beta-carboline and related compounds.
REFERENCES:
patent: 3029247 (1962-04-01), Schut
patent: 3036081 (1962-05-01), Nomine
patent: 3304309 (1967-02-01), Shavel et al.
patent: 3492304 (1970-01-01), Shavel
patent: 4614807 (1986-09-01), Flaugh
Narayanan, K.; et al J. Org. Chem. 1991, 56, pp. 359-365.
Chem. Abstract, "90(25):203905e", vol. 90, p. 609 (1979).
Chem. Abstract, "94(3):15940w", vol. 94, p. 465 (1981).
Chem. Abstract, "66(21):95019n", vol. 66, p. 890 (1967).
Chem. Abstract, "88(21):145971u", vol. 88, p. 22 (1978).
Chem. Abstracts, "78(19):124791p", vol. 78, p. 505 (1973).
Derwent Publications, "J56045-459", Otsuka Pharm KK, filed Sep. 20, 1979, published Apr. 25, 1981.
Derwent Publications, "J55133-360", Shonot, filed Apr. 3, 1979, published Oct. 17, 1980.
Derwent Publications, "J50077-396", Nippon Chemifar, filed Nov. 13, 1973, published Jun. 24, 1975.
Derwent Publications, "J50024-299", Nippon Chemifar, filed Jun. 28, 1973, published Mar. 15, 1975.
Derwent Publications, "26,841", Upjohn Co., filed Jun. 11, 1963, published Jun. 1, 1967.
A. R. Stoit, et al., Heterocycles 22(8), 1687-91 (1984).
Shono et al., J. Org. Chem., 48:1621-1628 (1983).
Liu et al., J. Org. Chem., 48(1) 44-47 (1983).
Hudlicky et al., J. Org. Chem., 46:1738-1741 (1981).
J. Org. Chem., 47:2229-2231 (1982).
Chem. Abstracts, "90(5):34483b", vol. 113, p. 25 (1990).
Chem. Abstracts, (Organic Chemistry) 4666 citing Chem. Listy 51, 1915-22 (1957).
Chem. Abstrcts, vol. 52:11039 citing Monatsh. Chem. 88, 1087-94 (1958).
Chem. Abstracts, vol. 54:1584 citing Czech. 86, 787 (1957).
Chem. Abstracts, vol. 55:21156 citing Bull. Soc. Chim. France, 643-653 (1960).
A. J. Bojarski et al. Pharmazie 48:289-294 (1993).
Derwent Publications, "88-251823/36" citing EP-281,242A (Feb. 2, 1987) (Eli Lilly).
Derwent Publications, "89-060798/08" citing U.S. 4,803,218 (Sep. 29, 1982). (McNeil).
Derwent Publications, "24,852" Oct. 20, 1961 SANO (Sandoz).
Derwent Publications, "15824e/09" citing BE-889,931 (Aug. 12, 1980) (Glaxo Group Ltd).
Chem. Abstract, "109(11):93404s", vol. 109, p. 751 (1988).
Chem. Abstract, "83(13):114719K", vol. 83, p. 591 (1975).
Chem. Abstract, "72(19):100674c", vol. 72, p. 374 (1970).
Chem. Abstract, "77(25):164922t", vol. 77, (1972).
Chem. Abstract, "94(11):84091g", vol. 94, p. 726 (1981).
Chem. Abstract, "111(23):208701x", vol. 111, (1989).
Audia James E.
Droste James J.
Evrard Deborah A.
Fludzinski Pawel
Murdoch Gwyn L.
Boone David E.
Dahlen Garth M.
Eli Lilly and Company
Ivy C. Warren
Vorndran-Jones MaCharri
LandOfFree
Tetrahydro-beta-carbolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydro-beta-carbolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydro-beta-carbolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-325346